High frequencies of PMN-MDSCs are associated with low suppressive capacity in advanced stages of HIV-1 infection

Table 1 Characteristics of the study subjects at blood draw

	CD4 cell count (median, cells/ μl)	range	HIV-RNA (median, copies/ ml)	range	PMN-MDSC frequencies (median, %)	range
PR (n = 10)	80	4–355	276,802	2100-5,999,674	2.37	0.23–14.41
CO (n = 5)	923	644–1085	40	< 40–1940	0.13	0.09–0.44
BRO (n = 6)	n.s.	n.s.	n.a.	n.a.	2.84	1.62–6.76
HC (n = 5)	n.s.	n.s.	n.a.	n.a.	0.48	0.11–1.85

PR progressors, CO controllers, BRO patients with advanced-stage non-small cell lung carcinoma (NSCLC): disease stage III and IV; HC healthy controls, n.s. not specified, n.a. not applicable.

ISSN: 2396-832X